Philadelphia, PA, United States of America

Casey Halpern

This inventor holds 6 USPTO granted patents and 8 published patent applications. Top assignees: Leland Stanford Junior University, Synchneuro, Inc.. Active years: 2023-2026.

USPTO Granted Patents = 6 

% Patents Active = 83.3

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2023-2026

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations by Inventor Casey Halpern

Introduction

Casey Halpern is an innovative inventor based in Philadelphia, PA (US). He has made significant contributions to the field of wearable technology and health monitoring. With a focus on brain activity and its correlation to blood glucose levels, Halpern's work is paving the way for advancements in diabetes management.

Latest Patents

Halpern holds 6 patents related to his groundbreaking research. His latest patents include a method for predicting blood glucose states based on sensed brain activity. This technology utilizes wearable sensors that can record brain activity signals and communicate this data to a remote device. The prediction models can provide real-time or future glucose states, enhancing the ability to manage diabetes effectively.

Career Highlights

Halpern is currently associated with Synchneuro, Inc., where he continues to develop innovative solutions in health technology. His work is characterized by a commitment to improving patient outcomes through advanced monitoring techniques.

Collaborations

Halpern collaborates with talented individuals such as Emily Mirro and Cammie Rolle, who contribute to the innovative environment at Synchneuro, Inc. Their teamwork fosters creativity and drives the development of cutting-edge technologies.

Conclusion

Casey Halpern's contributions to the field of wearable health technology are noteworthy. His patents and ongoing work at Synchneuro, Inc. highlight his dedication to improving health monitoring through innovative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…